Tag

Pharma & Agro Intermediates

1 article

Tatva Chintan Q4 FY26 Revenue Up 24% YoY

Tatva Chintan reported Q4 FY26 revenue of INR1,341 million, up 24% YoY, with EBITDA surging 214% YoY to INR281 million. Electrolyte Salts segment grew 865% QoQ to INR131 million, while Structured Dire